We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

73 hedge funds and large institutions have $854M invested in Tempest Therapeutics in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 3

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

250% more capital invested

Capital invested by funds: $244M → $854M (+$610M)

38% more funds holding

Funds holding: 53 → 73 (+20)

36% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 14

Holders
73
Holders Change
+20
Holders Change %
+37.74%
% of All Funds
1.95%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.13%
New
25
Increased
19
Reduced
14
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.5M
2
JHIU
Janus Henderson Investors US
Colorado
+$8.71M
3
CAM
Cormorant Asset Management
Massachusetts
+$5.79M
4
HCM
Highbridge Capital Management
New York
+$4.76M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.03M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$12.7M
2
EA
Emerald Advisers
Pennsylvania
-$4.1M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$3.37M
4
NIP
Nicholas Investment Partners
California
-$2.49M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
51
Sophrosyne Capital
New York
$767K -$952K -13 -68%
PAM
52
Panagora Asset Management
Massachusetts
$731K -$293K -4 -40%
PPA
53
Parametric Portfolio Associates
Washington
$729K – – –
PNC Financial Services Group
54
PNC Financial Services Group
Pennsylvania
$719K +$439K +6 New
Connor, Clark & Lunn Investment Management (CC&L)
55
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$668K +$366K +5 New
Creative Planning
56
Creative Planning
Kansas
$624K +$366K +5 New
SO
57
STRS Ohio
Ohio
$601K +$293K +4 +400%
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$592K – – –
NFA
59
Nationwide Fund Advisors
Ohio
$516K – – –
DC
60
Deere & Company
Illinois
$513K +$293K +4 New
AllianceBernstein
61
AllianceBernstein
Tennessee
$500K +$293K +4 New
AIG
62
American International Group
New York
$451K – – –
BA
63
BlackRock Advisors
Delaware
$345K +$73.2K +1 +50%
CCI
64
Columbus Circle Investors
$321K +$146K +2 New
Wells Fargo
65
Wells Fargo
California
$264K +$146K +2 New
Goldman Sachs
66
Goldman Sachs
New York
$260K +$146K +2 New
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$158K -$73.2K -1 -50%
Citigroup
68
Citigroup
New York
$135K +$73.2K +1 New
Legal & General Group
69
Legal & General Group
United Kingdom
$117K +$73.2K +1 New
UBS Group
70
UBS Group
Switzerland
$86K +$73.2K +1 New
Barclays
71
Barclays
United Kingdom
$82K +$73.2K +1 New
Bank of America
72
Bank of America
North Carolina
$71K – – –
QT
73
Quantbot Technologies
New York
$49K – – –
WEC
74
Winslow Evans & Crocker
Massachusetts
$44.2K – – –
LTFS
75
Ladenburg Thalmann Financial Services
Florida
$33K – – –
1 2
3
4

TPST Hedge Fund Activity: Q4 2014 in Review

73 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2014, worth a combined $854M — up 250% from $244M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TPST positions and 3 closed out — a net gain of 22 holders — while 19 added to existing stakes and 14 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $18.5M. The largest seller was Deerfield Management, cutting an estimated $12.7M.

  • 73 institutional investors held Tempest Therapeutics (TPST) as of Q4 2014, up from 53 in Q3 2014.
  • Funds reported $854M of Tempest Therapeutics stock for Q4 2014, up 250% quarter-over-quarter.
  • 25 funds opened new Tempest Therapeutics positions in Q4 2014 and 3 closed out, a net change of +22 holders.
  • The largest Tempest Therapeutics buyer in Q4 2014 was Fidelity Investments, an estimated $18.5M added.
  • The largest Tempest Therapeutics seller in Q4 2014 was Deerfield Management, an estimated $12.7M sold.

Based on aggregated 13F filings for Q4 2014.